Stockscreener 앱 받기
2.05
1.49%
0.03
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
Statistical indicators supporting ProQR Therapeutics N.V.’s strength2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser
What is the earnings history of ProQR Therapeutics N.V.Weekly Profit Analysis & Weekly Sector Rotation Insights - newsyoung.net
Will ProQR Therapeutics N.V. see short term momentum2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
ProQR Therapeutics N.V. stock outlook for YEARPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser
Is ProQR Therapeutics N.V. stock entering bullish territoryEarnings Overview Report & AI Forecasted Entry and Exit Points - Newser
Published on: 2025-08-16 03:26:16 - Newser
Can ProQR Therapeutics N.V. rally from current levels2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
How to track smart money flows in ProQR Therapeutics N.V.Portfolio Update Summary & Stepwise Swing Trade Plans - Newser
Using economic indicators to assess ProQR Therapeutics N.V. potentialPortfolio Performance Report & Safe Capital Growth Plans - Newser
Real time alert setup for ProQR Therapeutics N.V. performance2025 Price Momentum & Short-Term Trading Alerts - Newser
Will breakout in ProQR Therapeutics N.V. lead to full recoveryJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - Newser
Candlestick signals on ProQR Therapeutics N.V. stock todayWeekly Trade Report & Weekly Sector Rotation Insights - Newser
How institutional ownership impacts ProQR Therapeutics N.V. stockJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser
ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles - Investing.com Nigeria
How to build a dashboard for ProQR Therapeutics N.V. stock2025 Macro Impact & Fast Entry Momentum Alerts - Newser
ProQR Therapeutics (NASDAQ:PRQR) Earns Buy Rating from Chardan Capital - MarketBeat
How high can ProQR Therapeutics N.V. stock goShare Buyback & Technical Entry and Exit Tips - Newser
Real time breakdown of ProQR Therapeutics N.V. stock performanceInsider Selling & Intraday High Probability Alerts - Newser
Can ProQR Therapeutics N.V. recover in the next quarter2025 Price Action Summary & Long-Term Growth Plans - Newser
How to forecast ProQR Therapeutics N.V. trends using time seriesMomentum Prediction Based on AI Backtesting - Newser
What to do if you’re stuck in ProQR Therapeutics N.V.Share Buyback & Real-Time Buy Signal Notifications - Newser
Is ProQR Therapeutics N.V. stock a growth or value playMarket Performance Recap & Consistent Profit Alerts - Newser
Buy Signal for ProQR Therapeutics N.V. Stock Key Technical Indicators to WatchFree Confirmed Setup With Expert Accuracy - Newser
ProQR Therapeutics (NASDAQ:PRQR) Stock Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat
Volume spikes in ProQR Therapeutics N.V. stock – what they meanSummary of Trade Cycles in 5-Year Range - Newser
ProQR's Strategic Advancements and Clinical Prospects Drive Buy Rating with $12 Price Target - AInvest
Live market analysis of ProQR Therapeutics N.V.Safe Momentum Strategy With Trend Analysis - Newser
Published on: 2025-08-10 23:41:36 - Newser
Using Ichimoku Cloud for ProQR Therapeutics N.V. technicalsFree Price Action Based Buy Opportunity List - Newser
Ranking ProQR Therapeutics N.V. among high performing stocks via toolsTechnical Safety Zone Pattern Recognition - Newser
ProQR Therapeutics (PRQR) to Release Earnings on Thursday - MarketBeat
Is ProQR Therapeutics N.V. in Accumulation Phase NowMarket Momentum Signal Generator Shows Trends - beatles.ru
0.41%
0.88%
자본화:
|
볼륨(24시간):